ReviewEndocrine-related cancer2018
Advances in adrenal tumors 2018.
Review in Endocrine-related cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Binary Particle Swarm Optimization Intelligent Feature Optimization Algorithm-Based Magnetic Resonance Image in the Diagnosis of Adrenal Tumor.Contrast media & molecular imaging · 2022Trial
- Lateral transperitoneal laparoscopic adrenalectomy: A single-centre experience of 21 procedures.Open medicine (Warsaw, Poland) · 2025Article
- Minimally Invasive Image-Guided Percutaneous Irreversible Electroporation of Adrenal Metastases.Cardiovascular and interventional radiology · 2025Article
- Using CT radiomic features based on machine learning models to subtype adrenal adenoma.BMC cancer · 2023Article
- Analysis of adrenalectomy for the treatment of adrenal diseases performed by the Public Health Service in São Paulo between 2008 and 2019.Revista do Colegio Brasileiro de Cirurgioes · 2022Article
- Outcomes following minimally invasive imagine-guided percutaneous ablation of adrenal glands.Gland surgery · 2020Review
- A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma.Scientific reports · 2020Article
- Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.Endocrine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review aims to provide clinicians and researchers with a condensed update on the most important studies in the field during 2017. We present the academic output measured by active clinical trials and peer-reviewed published manuscripts. The most important and contributory manuscripts were summarized for each diagnostic entity, with a particular focus on manuscripts that describe translational research that have the potential to improve clinical care. Finally, we highlight the importance of collaborations in adrenal tumor research, which allowed for these recent advances and provide structures for future success in this scientific field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.